Document is current
Any future updates will be listed below
-
Authors
He, Yunye https://orcid.org/0000-0001-8581-7826
Koido, Masaru https://orcid.org/0000-0002-0348-0666
Sutoh, Yoichi
Shi, Mingyang
Otsuka-Yamasaki, Yayoi
Munter, Hans Markus https://orcid.org/0000-0002-3165-2840
,
Murakami, Yoishinori
Morisaki, Takayuki
Nagai, Akiko
Murakami, Yoshinori https://orcid.org/0000-0002-2826-4396
Tanikawa, Chizu
Hachiya, Tsuyoshi https://orcid.org/0000-0002-5274-3266
Matsuda, Koichi https://orcid.org/0000-0001-7292-2686
Shimizu, Atsushi
Kamatani, Yoichiro https://orcid.org/0000-0001-8748-5597
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP18km0605001)
Japan Agency for Medical Research and Development (JP23tm0624002)
Japan Agency for Medical Research and Development (JP19km0405215)
Japan Agency for Medical Research and Development (JP223fa627011)
Japan Agency for Medical Research and Development (JP19km0405215)
Japan Agency for Medical Research and Development (JP18km0605001)
Japan Agency for Medical Research and Development (JP23tm0624002)
Japan Agency for Medical Research and Development (JP19km0405215)
Japan Agency for Medical Research and Development (JP223fa627011)
Japan Agency for Medical Research and Development (JP18km0605001)
Japan Agency for Medical Research and Development (JP23tm0624002)
- License Information
-
More Information
Article History
Received: 1 November 2022
Accepted: 12 October 2023
First Online: 30 November 2023
Competing interests
: Y.K. holds stock in StaGen Co. Ltd. T.H. is a board member of Genome Analytics Japan Inc. The other authors declare no competing interests.
